Position in NVS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,955,456
-$1,349,246 QoQ
Shares Held
25,239
-27.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#306
of 1,602 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Clearstead Advisors, LLC holds $207,269,806 across 16 Drug Manufacturers - General names. NVS ranks #8 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
55,467 | $66,528,789 | |
| 2 | JNJ |
Johnson & Johnson
|
234,177 | $59,473,932 | |
| 3 | ABBV |
AbbVie Inc.
|
111,021 | $27,937,324 | |
| 4 | AMGN |
Amgen Inc
|
40,211 | $14,561,207 | |
| 5 | MRK |
Merck & Co., Inc.
|
112,376 | $14,440,316 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
128,389 | $7,397,774 | |
| 7 | PFE |
Pfizer Inc
|
197,145 | $4,747,251 | |
| 8 | NVS |
Novartis AG
This page
|
25,239 | $3,955,456 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,955,456 | 25,239 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $5,304,702 | 34,728 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $2,637,453 | 19,130 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,438,868 | 19,018 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,304,514 | 19,044 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,108,755 | 18,916 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,851,128 | 19,023 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,260,258 | 19,651 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,305,923 | 21,660 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,069,828 | 21,398 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,160,556 | 21,398 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,332,186 | 22,896 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $2,308,215 | 22,874 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $2,096,128 | 22,784 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $2,066,964 | 22,784 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,830,624 | 24,084 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $2,063,715 | 24,414 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,142,328 | 24,414 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $2,135,492 | 24,414 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,021,438 | 24,718 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,293,591 | 25,138 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,410,450 | 28,199 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,655,654 | 28,123 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,437,054 | 28,025 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,507,007 | 28,704 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,504,217 | 18,244 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||